AngioDynamics, Inc. (ANGO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31..
Quick ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 74.72M USD | Liabilities, Current |
| Cash and equivalents | 53.86M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | 48.33M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 52.44M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | (m) | $74.72M | $53.86M | (m) | $48.33M | $52.44M | (m) |
| 2026-02-28 | (m) | $66.07M | $37.81M | (m) | $45.55M | $58.58M | (m) |
| 2025-11-30 | (m) | $71.96M | $41.64M | (m) | $44.43M | $65.57M | (m) |
| 2025-08-31 | (m) | $68.28M | $38.76M | (m) | $42.64M | $62.26M | (m) |
| 2025-05-31 | (m) | $76.20M | $55.89M | (m) | $42.89M | $62.01M | (m) |
| 2025-02-28 | (m) | $77.97M | $44.76M | (m) | $43.47M | $63.10M | (m) |
| 2024-11-30 | (m) | $88.59M | $54.09M | (m) | $43.16M | $65.92M | (m) |
| 2024-08-31 | (m) | $76.70M | $55.01M | (m) | $39.56M | $64.70M | (m) |
| 2024-05-31 | (m) | $91.16M | $76.06M | (m) | $43.61M | $60.62M | (m) |
| 2024-02-29 | (m) | $85.87M | $78.45M | (m) | $49.48M | $58.07M | (m) |
| 2023-11-30 | (m) | $78.04M | $60.90M | (m) | $51.60M | $64.25M | (m) |
| 2023-08-31 | (m) | $57.45M | $57.59M | (m) | $49.76M | $59.97M | (m) |
| 2023-05-31 | (m) | $83.83M | $44.62M | (m) | $52.83M | $55.33M | (m) |
| 2023-02-28 | (m) | $69.63M | $30.11M | (m) | $50.89M | $63.53M | (m) |
| 2022-11-30 | (m) | $73.57M | $29.86M | (m) | $52.85M | $63.18M | (m) |
| 2022-08-31 | (m) | $66.39M | $24.56M | (m) | $53.59M | $57.61M | (m) |
| 2022-05-31 | (m) | $74.32M | $28.82M | (m) | $52.30M | $51.39M | (m) |
| 2022-02-28 | (m) | $49.37M | $23.89M | (m) | $41.81M | $48.04M | (m) |
| 2021-11-30 | (m) | $54.48M | $34.29M | (m) | $38.20M | $48.18M | (m) |
| 2021-08-31 | (m) | $52.10M | $35.47M | (m) | $35.42M | $49.30M | (m) |
| 2021-05-31 | (m) | $57.58M | $48.16M | (m) | $35.41M | $48.61M | (m) |
| 2021-02-28 | (m) | $50.26M | $54.47M | (m) | $33.17M | $49.01M | (m) |
| 2020-11-30 | (m) | $45.81M | $58.02M | (m) | $33.60M | $49.58M | (m) |
| 2020-08-31 | (m) | $39.85M | $47.93M | (m) | $33.59M | $52.76M | (m) |
| 2020-05-31 | (m) | $51.45M | $54.44M | (m) | $31.26M | $59.91M | (m) |
| 2020-02-29 | (m) | $48.71M | $27.16M | (m) | $35.62M | $54.90M | (m) |
| 2019-11-30 | (m) | $57.01M | $41.25M | (m) | $33.99M | $50.24M | (m) |
| 2019-08-31 | (m) | $47.17M | $83.65M | (m) | $32.54M | $45.23M | (m) |
| 2019-05-31 | $271.22M | $73.30M | $227.64M | $0.00 | $43.58M | $40.07M | 3.70× |
| 2019-02-28 | $85.91M | $53.30M | $41.70M | $0.00 | $44.21M | $52.39M | 1.61× |
| 2018-11-30 | $87.54M | $49.70M | $42.82M | $1.35M | $43.37M | $50.64M | 1.76× |
| 2018-08-31 | $66.28M | $45.79M | $24.76M | $1.35M | $40.16M | $49.72M | 1.45× |
| 2018-05-31 | $114.81M | $57.30M | $74.10M | $1.32M | $39.40M | $48.92M | 2.00× |
| 2018-02-28 | $95.40M | $54.40M | $52.29M | $1.28M | $41.83M | $56.56M | 1.75× |
| 2017-11-30 | $93.19M | $59.66M | $49.86M | $1.26M | $42.07M | $54.03M | 1.56× |
| 2017-08-31 | $90.70M | $64.32M | $48.20M | $1.22M | $41.28M | $55.42M | 1.41× |
| 2017-05-31 | $93.28M | $71.52M | $47.54M | $1.22M | $44.52M | $54.51M | 1.30× |
| 2017-02-28 | $83.08M | $50.64M | $35.57M | $1.20M | $46.30M | $57.68M | 1.64× |
| 2016-11-30 | $87.04M | $50.75M | $35.66M | $1.20M | $50.17M | $56.67M | 1.71× |
| 2016-08-31 | $89.18M | $65.43M | $37.41M | $1.65M | $50.12M | $58.27M | 1.36× |
| 2016-05-31 | $86.85M | $66.73M | $32.33M | $1.65M | $52.87M | $55.37M | 1.30× |
| 2016-02-29 | $78.01M | $61.58M | $21.90M | $1.67M | $54.45M | $65.79M | 1.27× |
| 2015-11-30 | $73.75M | $60.10M | $19.00M | $1.64M | $53.12M | $70.81M | 1.23× |
| 2015-08-31 | $74.38M | $60.65M | $20.27M | $1.69M | $52.42M | $74.33M | 1.23× |
| 2015-05-31 | $78.51M | $61.16M | $18.39M | $1.69M | $58.43M | $67.39M | 1.28× |
| 2015-02-28 | $79.16M | $59.69M | $19.70M | $1.68M | $57.77M | $68.71M | 1.33× |
| 2014-11-30 | $75.13M | $57.94M | $14.88M | $1.70M | $58.56M | $75.31M | 1.30× |
| 2014-08-31 | $71.50M | $63.71M | $13.81M | $1.67M | $56.03M | $70.42M | 1.12× |
| 2014-05-31 | $80.06M | $72.29M | $16.11M | $1.81M | $62.15M | $61.06M | 1.11× |
| 2014-02-28 | $66.92M | $63.38M | $7.38M | $1.81M | $57.73M | $59.83M | 1.06× |
| 2013-11-30 | $65.43M | $69.08M | $15.17M | $1.85M | $48.41M | $60.05M | 0.95× |
| 2013-08-31 | $70.48M | $74.36M | $22.07M | $1.85M | $46.56M | $59.25M | 0.95× |
| 2013-05-31 | $71.75M | $63.44M | $21.80M | $2.15M | $47.79M | $55.06M | 1.13× |
| 2013-02-28 | $63.89M | $66.83M | $16.63M | $2.15M | $45.11M | $61.97M | 0.96× |
| 2012-11-30 | $68.56M | $60.38M | $19.32M | $2.15M | $47.09M | $62.33M | 1.14× |
| 2012-08-31 | $75.95M | $52.38M | $18.90M | $11.63M | $45.43M | $63.41M | 1.45× |
| 2012-05-31 | $86.17M | $55.42M | $23.51M | $14.07M | $48.59M | $55.82M | 1.55× |
| 2012-05-22 | (m) | (m) | $23.51M | (m) | (m) | (m) | (m) |
| 2012-02-29 | $169.75M | $29.19M | $34.05M | $108.98M | $26.72M | $28.16M | 5.81× |
| 2011-11-30 | $167.77M | $26.62M | $42.95M | $93.36M | $31.45M | $29.43M | 6.30× |
| 2011-08-31 | $163.02M | $24.11M | $50.49M | $86.16M | $26.36M | $29.67M | 6.76× |
| 2011-05-31 | $158.68M | $25.51M | $45.98M | $85.56M | $27.14M | $28.13M | 6.22× |
| 2011-02-28 | (m) | (m) | $35.26M | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | $27.13M | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | $67.20M | (m) | (m) | (m) | (m) |
| 2010-05-31 | (m) | (m) | $58.76M | (m) | (m) | (m) | (m) |
| 2009-05-31 | (m) | (m) | $27.91M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |